The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Influenza Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
The global Influenza Diagnostics market size is expected to reach US$ 3599.9 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Influenza Diagnostics in various end use industries. The expanding demands from the Hospitals, POCT and Others,, are propelling Influenza Diagnostics market. RIDT, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RT-PCR segment is estimated at % CAGR for the next seven-year period.
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Influenza Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Influenza Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Influenza Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Influenza Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Influenza Diagnostics covered in this report include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience and BioMerieux, etc.
The global Influenza Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Global Influenza Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Influenza Diagnostics market, Segment by Type:
RIDT
RT-PCR
Cell Culture
Others
Global Influenza Diagnostics market, by Application
Hospitals
POCT
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Influenza Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
The global Influenza Diagnostics market size is expected to reach US$ 3599.9 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Influenza Diagnostics in various end use industries. The expanding demands from the Hospitals, POCT and Others,, are propelling Influenza Diagnostics market. RIDT, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RT-PCR segment is estimated at % CAGR for the next seven-year period.
North America is the largest consumption place, with a consumption marker share nearly 53%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
The main manufacturers are BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience, BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific etc. BD is the largest manufacturer with about 19% market share.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Influenza Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Influenza Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Influenza Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Influenza Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Influenza Diagnostics covered in this report include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience and BioMerieux, etc.
The global Influenza Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific
Global Influenza Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Influenza Diagnostics market, Segment by Type:
RIDT
RT-PCR
Cell Culture
Others
Global Influenza Diagnostics market, by Application
Hospitals
POCT
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Influenza Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Influenza Diagnostics
1.1 Influenza Diagnostics Market Overview
1.1.1 Influenza Diagnostics Product Scope
1.1.2 Influenza Diagnostics Market Status and Outlook
1.2 Global Influenza Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Influenza Diagnostics Market Size by Region (2018-2029)
1.4 Global Influenza Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Influenza Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Influenza Diagnostics Market Size (2018-2029)
1.6.1 North America Influenza Diagnostics Market Size (2018-2029)
1.6.2 Europe Influenza Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Influenza Diagnostics Market Size (2018-2029)
1.6.4 Latin America Influenza Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Influenza Diagnostics Market Size (2018-2029)
2 Influenza Diagnostics Market by Type
2.1 Introduction
2.1.1 RIDT
2.1.2 RT-PCR
2.1.3 Cell Culture
2.1.4 Others
2.2 Global Influenza Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Influenza Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Influenza Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Influenza Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Influenza Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Influenza Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Influenza Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Influenza Diagnostics Revenue Breakdown by Type (2018-2029)
3 Influenza Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 POCT
3.1.3 Others
3.2 Global Influenza Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Influenza Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Influenza Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Influenza Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Influenza Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Influenza Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Influenza Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Influenza Diagnostics Revenue Breakdown by Application (2018-2029)
4 Influenza Diagnostics Competition Analysis by Players
4.1 Global Influenza Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2022)
4.3 Date of Key Players Enter into Influenza Diagnostics Market
4.4 Global Top Players Influenza Diagnostics Headquarters and Area Served
4.5 Key Players Influenza Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Influenza Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BD
5.1.1 BD Profile
5.1.2 BD Main Business
5.1.3 BD Influenza Diagnostics Products, Services and Solutions
5.1.4 BD Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 BD Recent Developments
5.2 Abbott (Include Alere)
5.2.1 Abbott (Include Alere) Profile
5.2.2 Abbott (Include Alere) Main Business
5.2.3 Abbott (Include Alere) Influenza Diagnostics Products, Services and Solutions
5.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott (Include Alere) Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Influenza Diagnostics Products, Services and Solutions
5.3.4 Roche Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 SIEMENS Recent Developments
5.4 SIEMENS
5.4.1 SIEMENS Profile
5.4.2 SIEMENS Main Business
5.4.3 SIEMENS Influenza Diagnostics Products, Services and Solutions
5.4.4 SIEMENS Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 SIEMENS Recent Developments
5.5 Analytik Jena
5.5.1 Analytik Jena Profile
5.5.2 Analytik Jena Main Business
5.5.3 Analytik Jena Influenza Diagnostics Products, Services and Solutions
5.5.4 Analytik Jena Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Analytik Jena Recent Developments
5.6 Quidel
5.6.1 Quidel Profile
5.6.2 Quidel Main Business
5.6.3 Quidel Influenza Diagnostics Products, Services and Solutions
5.6.4 Quidel Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Quidel Recent Developments
5.7 Thermo Fisher
5.7.1 Thermo Fisher Profile
5.7.2 Thermo Fisher Main Business
5.7.3 Thermo Fisher Influenza Diagnostics Products, Services and Solutions
5.7.4 Thermo Fisher Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Thermo Fisher Recent Developments
5.8 Meridian Bioscience
5.8.1 Meridian Bioscience Profile
5.8.2 Meridian Bioscience Main Business
5.8.3 Meridian Bioscience Influenza Diagnostics Products, Services and Solutions
5.8.4 Meridian Bioscience Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Meridian Bioscience Recent Developments
5.9 BioMerieux
5.9.1 BioMerieux Profile
5.9.2 BioMerieux Main Business
5.9.3 BioMerieux Influenza Diagnostics Products, Services and Solutions
5.9.4 BioMerieux Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 BioMerieux Recent Developments
5.10 Sekisui Diagnostics
5.10.1 Sekisui Diagnostics Profile
5.10.2 Sekisui Diagnostics Main Business
5.10.3 Sekisui Diagnostics Influenza Diagnostics Products, Services and Solutions
5.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Sekisui Diagnostics Recent Developments
5.11 Response Biomedical
5.11.1 Response Biomedical Profile
5.11.2 Response Biomedical Main Business
5.11.3 Response Biomedical Influenza Diagnostics Products, Services and Solutions
5.11.4 Response Biomedical Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Response Biomedical Recent Developments
5.12 SA Scientific
5.12.1 SA Scientific Profile
5.12.2 SA Scientific Main Business
5.12.3 SA Scientific Influenza Diagnostics Products, Services and Solutions
5.12.4 SA Scientific Influenza Diagnostics Revenue (US$ Million) & (2018-2023)
5.12.5 SA Scientific Recent Developments
6 North America
6.1 North America Influenza Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Influenza Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Influenza Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Influenza Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Influenza Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Influenza Diagnostics Market Dynamics
11.1 Influenza Diagnostics Industry Trends
11.2 Influenza Diagnostics Market Drivers
11.3 Influenza Diagnostics Market Challenges
11.4 Influenza Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
